Eastman Chemical (EMN) Misses Q3 EPS by 2c
Tweet
Share
E-mail
Get Alerts EMN Hot Sheet
Price: $71.19 --0%
Revenue Growth %: +10.0%
Financial Fact:
Selling, general and administrative expenses: 181M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +10.0%
Financial Fact:
Selling, general and administrative expenses: 181M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Eastman Chemical (NYSE: EMN) reported Q3 EPS of $2.46, $0.02 worse than the analyst estimate of $2.48. Revenue for the quarter came in at $2.72 billion versus the consensus estimate of $2.61 billion.
For earnings history and earnings-related data on Eastman Chemical (EMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Barclays Downgrades Ipsen SA (IPN:FP) (IPSEF) to Underweight
- Seaport Global Securities Upgrades Asbury Automotive Group (ABG) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
